Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122180) titled 'Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus' on Aug. 7.

Study Type: Observational

Primary Sponsor: MDCECRO LLC

Condition: Diabetes Mellitus

Intervention: Device: CT3 Series Continuous Glucose Monitoring System:

Recruitment Status: Recruiting

Date of First Enrollment: June 4, 2025

Target Sample Size: 72

Countries of Recruitment: Latvia

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122180

Published by HT Digital Content S...